research use only
Cat.No.P1201
Amino-acid Sequence
CAS No. 154947-66-7
Selleck's LL37 (Human cathelicidin) Has Been Cited by 3 Publications
| Featured Inhibitors | Y-27632 Dihydrochloride SB431542 CHIR-99021 (Laduviglusib) RMC-7977 RMC-6236 (Daraxonrasib) MRTX1133 MG132 Z-VAD-FMK VT3989 IAG933 |
|---|
| Storage (From the date of receipt) | 3 years -20°C powder | ||
|
In vitro |
Water : 100 mg/mL |
Molecular Weight Calculator |
|
In vivo Add solvents to the product individually and in order. |
In vivo Formulation Calculator |
||||
| Description | LL37 (Human cathelicidin, Ropocamptide) is a cathelicidin-related antimicrobial peptide with potent chemotactic and immunomodulatory properties. |
|---|
In vitro |
||||
| In vitro | LL-37, human is a 37-residue, amphipathic, cathelicidin-derived antimicrobial peptide, which exhibits a broad spectrum of antimicrobial activity. LL-37, human could help protect the cornea from infection and modulates wound healing |
|||
|---|---|---|---|---|
| Cell Research | Cell lines | HCECs | ||
| Concentrations | 1, 2.5, 5, 10 and 20 μg/mL | |||
| Incubation Time | 24 h | |||
| Method | Cells were treated with indicated concentrations of drug for 24 h. |
|||
References |
|
| Molecular Formula | C205H340N60O53 |
|---|---|
| Molecular Weight | 4493.26 |
| CAS No. | 154947-66-7 |
| Appearance | White Powder |
| Peptide Content (by %N) | ≥80% |
| Purity (by HPLC) | 0.9862 |
| Single Impurity (by HPLC) | ≤1.0% |
| Assay (By Anhydrous, Acetic Acid-free) | 95.0~105.0% |
| MS | Consistent |
| Packing | plastic vial(dedicated for peptide packing) or glass vial, quantity according to customer's detail requirement. |
| Storage (From the date of receipt) |
3 years -20°C powder |
| Shipping | Room temperature shipping(Stability testing shows this product can be shipped without any cooling measures.) |